Galenica is one of the largest Greek pharmaceutical companies that promotes research and serves consistently and scientifically with health responsibility, developing high quality and innovative pharmaceutical proprietary products. It was founded in 1974 by two pharmacists, Dionysios Varelas and Vassilios Tamvakas, and very soon developed into one of the most dynamic companies in the industry, making enviable rates of progress and growth. It is the first Greek company that focused on acquiring know-how and securing the rights to use it, through cooperation with major research companies abroad but also on the development of its own know-how of original pharmaceuticals, which it already successfully exports to Balkan countries. In recent years it has been investing in biotechnology, recognizing the importance of its applications in the ability to discover new methods, both for the treatment and prevention of diseases. One of the key factors in the successful course of the company is due to the human resources that staff its departments, and which today amounts to 300 people.